Dry season mapping of savanna forage quality, using the hyperspectral Carnegie Airborne Observatory sensor by Knox, Nichola M., Skidmore, Andrew K., Prins, Herbert H.T., Asner, Gregory P., van der Werff, Harald M.A., de Boer, Willem F., van der Waal, Cornelis, de Knegt, Hendrik J., Kohi, Edward M., Slotow, Rob, Grant, Rina C.

Get full text

Socio‐economic factors associated with loss to follow‐up among individuals with HCV: A Dutch nationwide cross‐sectional study by Dijk, Marleen, Boyd, Anders, Brakenhoff, Sylvia M., Isfordink, Cas J., Zoest, Rosan A., Verhagen, Mark D., Knegt, Robert J., Drenth, Joost P. H., Valk, Marc, Wijngaarden, Peter, Douma, Renée A., Erkelens, Willemien G., Lammers, Adriana J. J., Jonge, Hendrik J. M., Bus, Paul J., Hollander, Jan G., Posthouwer, Dirk, Klemt‐Kropp, Michael, Baak, Lubbertus C.

Get full text

Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HBeAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up by van Campenhout, Margo J. H., Brouwer, Willem Pieter, Xie, Qing, Guo, S., Chi, Heng, Qi, Xun, Tabak, Fehmi, Streinu‐Cercel, Adrian, Wang, Ji‐Yao, Zhang, Ning‐Ping, Idilman, Ramazan, Reesink, Hendrik W., Diculescu, Mircea, Simon, Krzysztof, Akdogan, Meral, Mazur, Włodzimierz, de Knegt, Rob J., Verhey, Elke, Hansen, Bettina E., Janssen, Harry L. A.

Get full text

Potent immune activation in chronic hepatitis C patients upon administration of an oral inducer of endogenous interferons that acts via Toll-like receptor 7 by BOONSTRA, Andre, LIU, Bi-Sheng, BAUMAN, Lisa A, RAHIMY, Mohamad, APPLEMAN, James R, FREDDO, James L, REESINK, Hendrik W, DE KNEGT, Robert J, JANSSEN, Harry La, GROOTHUISMINK, Zwier Ma, BERGMANN, Jilling F, DE BRUIJNE, Joep, HOTHO, Daphne M, HANSEN, Bettina E, VLIET, Andre A.van, DE WETERING DE ROOIJ, Jeroen Van, FLETCHER, Simon P

Get full text

Long‐term follow‐up of patients treated with entecavir and peginterferon add‐on therapy for HB eAg‐positive chronic hepatitis B infection: ARES long‐term follow‐up by van Campenhout, Margo J. H., Brouwer, Willem Pieter, Xie, Qing, Guo, S., Chi, Heng, Qi, Xun, Tabak, Fehmi, Streinu‐Cercel, Adrian, Wang, Ji‐Yao, Zhang, Ning‐Ping, Idilman, Ramazan, Reesink, Hendrik W., Diculescu, Mircea, Simon, Krzysztof, Akdogan, Meral, Mazur, Włodzimierz, de Knegt, Rob J., Verhey, Elke, Hansen, Bettina E., Janssen, Harry L. A.

Get full text

Pharmacokinetics and antiviral activity of PHX1766, a novel HCV protease inhibitor, using an accelerated Phase I study design by HOTHO, Daphne M, DE BRUIJNE, Joep, SCHINKEL, Janke, MOLENKAMP, Richard, DE WETERING DE ROOIJ, Jeroen Van, VLIET, Andre Van, JANSSEN, Harry La, DE KNEGT, Robert J, REESINK, Hendrik W, O'FARRELL, A. Marie, BOYEA, Teresa, JIANKE LI, BRACKEN, Michele, XIN LI, CAMPBELL, David, GULER, Hans-Peter, WEEGINK, Christine J

Get full text

Safety and antiviral activity of JTK-652: a novel HCV infection inhibitor by de Bruijne, Joep, Bergmann, Jilling F, Weegink, Christine J, van Nieuwkerk, Carin M J, de Knegt, Robert J, Komoda, Yasumasa, van de Wetering de Rooij, Jeroen J, van Vliet, Andre, Jansen, Peter L M, Molenkamp, Richard, Schinkel, Janke, Reesink, Hendrik, Janssen, Harry L A

Get full text